Author Affiliation: Office of the Chancellor, University of California, San Francisco.
At a time when jobs seem scarce, one role seems to have multiplied: the pundit; never at a loss for a provocative, deeply held view or opinion. And, one of the rapidly expanding punditry themes is focused on the purported “evils” of the pharmaceutical industry and the potential for an associated corrupting influence of money on innovation in health. In his new book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, Ben Goldacre, BA, MBBS, MA, MRCPsych,1 a British physician and writer, says
Desmond-Hellmann S. Improving Health With Partnerships Between Academia and Industry. JAMA Intern Med. 2013;173(12):1051–1052. doi:10.1001/jamainternmed.2013.826
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.